Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma

Acta Oncologica

Volumn 47, Issue 7, 2008, Pages 1325-1336

  Pötter, Richard ^a   Kirisits, Christian ^a   Fidarova, Elena F ^a   Dimopoulos, Johannes C A ^a   Berger, Daniel ^a   Tanderup, Kari ^b   Lindegaard, Jacob C ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; BRACHYTHERAPY; CANCER RADIOTHERAPY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMAGE PROCESSING; IMAGE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOBIOLOGY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

BRACHYTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 51049115153     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802282794     Document Type: Review

References (50)

1. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235-45.
2. Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): Concepts and terms in 3D image based treatment planning in cervix cancer brachytherapy: Aspects of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol 2006;78:67-77.
3. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer. Int J Radiat Oncol Biol Phys 2005;62:901-11.
4. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2007; doi:10.1016/j.radonc.2007.10.026
5. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:756-64.
6. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007;83:148-55.
7. Van Dyk S, Bernshaw D. Ultrasound-based conformal planning for gynaecological brachytherapy. J Med Imaging Radiat Oncol 2008;52:77-84.
8. Lin LL, Mutic S, Low DA, LaForest R, Vicic M, Zoberi I, et al. Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET. Int J Radiat Oncol Biol Phys 2007;67:91-6.
9. Pötter R, Fidarova E, Kirisits C, Dimopoulos J. Image-guided adaptive brachytherapy for cervix carcinoma. Clin Oncol 2008; doi:10.1016/j.clon.2008.04.011.
10. Pötter R. Modern imaging in brachytherapy. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO Handbook of Brachytherapy. Brussels: ESTRO; 2002. p. 123-51.
11. Lim K, Chan P, Dinniwell R, Fyles A, Haider M, Cho YB, et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: Radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 2008;70:126-33.
12. Dimopoulos J, Schard G, Kirisits C, Lang S, Baldinger A, Helbich ThH, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2008(in press).
13. Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Pötter R. Image-guided radiotherapy for cervix cancer: High-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008; doi:10.1016/j.ijrobp.2008.03.032
14. Nulens A, Lang S, Briot E, De Brabandere M, Kirisits C, Dimopoulos J, et al. Evaluation of contouring concepts and dose volume parameters of MR based brachytherapy treatment plans for cervix cancer: Results and conclusions of the GEC-ESTRO GYN working group delineation workshops. Radiother Oncol 2005;75(S1):S9.
15. Lang S, Nulens A, Briot E, Kirisits C, De Brabandere M, Dumas I, et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006;78:185-93.
16. Dimopoulos J, De Vos V, Berger D, Petric P, Dumas I, Kirisits C, et al. Interobserver comparison of target delineation for MRI-assisted cervical cancer brachytherapy: Application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2008 (in press).
17. Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Pötter R. Inter- and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008 (in press).
18. Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. CT- versus MRI-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007;68:491-8.
19. Dimopoulos J, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: Potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 2006;64:1380-8.
20. Fellner C, Pötter R, Knocke TH, Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001;58:53-62.
21. Kim RY, Pareek P. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: Analysis of dose-volume histograms. Brachytherapy 2003;2:200-6.
22. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005;62:131-7.
23. Hellebust TP, Tanderup K, Bergstrand ES, Knutsen BH, Røislien J, Olsen DR. Reconstruction of a ring applicator using CT imaging: Impact of the reconstruction method and applicator orientation. Phys Med Biol 2007;52:4893-904.
24. Berger D, Dimopoulos J, Pötter R, Kirisits C. The reconstruction of brachytherapy ring applicators directly on MR images. Radiother Oncol 2008 (in press).
25. Haack S, Lindegaard JC, Nielsen SK, Gelineck J, Tanderup K. Applicator reconstruction in MRI 3D image based dose planning of brachytherapy for cervical cancer, Radiother Oncol 2008 (in press).
26. Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008 (in press).
27. Lang S, Georg P, Kirisits C, Dimopoulos J, Kuzucan D, Georg D, et al. Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repeated MRI examinations: DVH variations between two HDR fractions within one applicator insertion. Radiother Oncol 2006;81(S1):S79.
28. Tanderup K, Christensen JJ, Granfeldt J, Lindegaard JC. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. Radiother Oncol 2006;79:87-93.
29. Hellebust TP, Dale E, Skjønsberg A, Olsen DR. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations. Radiother Oncol 2001;60:273-80.
30. Kirisits C, Lang S, Dimopoulos J, Oechs K, Georg D, Pötter R. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer. Radiother Oncol 2006;81:269-75.
31. Davidson MT, Yuen J, D'Souza DP, Batchelar DL. Image-guided cervix high-dose-rate brachytherapy treatment planning: Does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk? Brachytherapy 2008;7:37-42.
32. Kirisits C, Lang S, Dimopoulos J, Oechs K, Georg D, Poetter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning and dosimetric results. Int J Radiat Oncol Biol Phys 2006;65:624-30.
33. Lang S, Kirisits C, Dimopoulos J, Georg D, Pötter R. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints. Int J Radiat Oncol Biol Phys 2007;69:619-27.
34. Bentzen SM, Baumann M. The linear-quadratic model in clinical practice. In: Steel GG. "Basic clinical radiobiology", 3rd edn. London: 2002. p 134-146.
35. Dörr W, Bentzen SM. Late functional response of mouse urinary bladder to fractionated X-irradiation. Int J Radiat Biol 1999;75:1307-15.
36. Orton CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001;49:183-9.
37. Thames H. Estimation of changes in tolerance dose with the large fraction sizes typical of stereotactic radiotherapy. Oral communication. ICRO ÖGRO 8, Salzburg, May 2007.
38. Chajon E, Dumas I, Touleimat M, Magné N, Coulot J, Verstraet R, et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 2007;69:955-61.
39. Dimopoulos J, Lang S, Kirisits C, Fidarova E, Berger D, Georg P, et al. Dose-volume histogram parameters and local tumour control in MR image guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2008 (in press).
40. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO Handbook of Brachytherapy. Brussels: ESTRO; 2002. p. 301-63.
41. ICRU Report 38. Dose and volume specification for reporting intracavitary therapy in gynaecology. International Commission on Radiation Units and Measurements, Bethesda, Maryland,1985.
42. Pötter R, Van Limbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol 2001;58:11-8.
43. Koom WS, Sohn DK, Kim JY, Kim JW, Shin KH, Yoon SM, et al. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys 2007;68:1446-54.
44. Georg P, Dimopoulos J, Kirisits C, Lang S, Berger D, Pötter R. Dose volume parameters in cervical cancer patients treated with MRI based brachytherapy and their predictive value for late adverse side effects in rectum, sigmoid and bladder. Radiother Oncol 2006;81(S1):S38-9.
45. Georg P, Kirisits C, Goldner G, Dörr W, Hammer J, Pötzi R, et al. Correlation of dose volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI based brachytherapy. Radiother Oncol 2008(in press).
46. Sturdza AE, Berger D, Lang S, Dimopoulos J, Thomas G, Georg P, et al. Uncertainties in assessing sigmoid dose volume parameters in MRI-guided fractionated HDR brachytherapy. Brachytherapy 2008;7:109.
47. Berger D, Dimopoulos J, Georg P, Georg D, Pötter R, Kirisits C. Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator. Int J Radiat Oncol Biol Phys 2007;67:1451-9.
48. Fidarova E, Schüssler S, Dimopoulos J, Bachtiary B, Georg P, Berger D, et al. An investigation into the relationship between MRI-based DVH parameters and vaginal morbidity in cervical cancer brachytherapy. Radiother Oncol 2008(in press).
49. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Pötter R. The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: Results of a prospective comparative trial. Radiother Oncol 2003;68:51-9.
50. Dimopoulos J, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006;66:83-90.